Hellenic journal of nuclear medicine · 2026
Giant primary hepatic osteosarcoma: A rare case report and review of the literature.
Клинический случайСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhu Haoliang, Sun Hangzhe, Zhang Tianyun, Chen Yu, Wang Siqi
Аннотация
OBJECTIVE: Primary hepatic extraskeletal osteosarcoma (PHOS) is an extremely rare and aggressive malignant tumor originating in the liver with no primary skeletal lesion. Less than 1% of all extraskeletal osteosarcomas occur in the liver, often presenting as a large abdominal mass with poor prognosis.
CASE PRESENTATION: We report a rare case of a 64-year-old man diagnosed with a giant PHOS (163×128×160mm) accompanied by pulmonary and lymph node metastases. Multimodal imaging magnetic resonance imaging (MRI), computed tomography (CT), bone scintigraphy, positron emission tomography (PET)/CT demonstrated a heterogeneous hepatic mass with extensive calcifications, rim enhancement, restricted diffusion, and elevated fluorine-18-fluorodeoxyglucose (18F-FDG) uptake. Histopathological analysis confirmed the diagnosis, showing atypical mesenchymal cells producing osteoid matrix with strong special AT-rich sequence-binding protein 2 (SATB2) positivity and negative epithelial markers.
DISCUSSION: Imaging characteristics and immunohistochemical profiling were crucial in differentiating PHOS from hepatocellular carcinoma and metastatic osteosarcoma. The case supports the metaplasia theory of PHOS pathogenesis and highlights its radiologic-pathologic correlation, especially the "cloud-like" enhancement on imaging corresponding to unmineralized osteoid and vascular proliferation.
CONCLUSION: This case highlights the diagnostic challenge and clinical significance of PHOS. Comprehensive imaging and pathological evaluation are essential for accurate diagnosis. Due to its rarity and aggressiveness, PHOS requires individualized management strategies, typically involving surgery and adjuvant therapies despite limited evidence-based guidelines.
CASE PRESENTATION: We report a rare case of a 64-year-old man diagnosed with a giant PHOS (163×128×160mm) accompanied by pulmonary and lymph node metastases. Multimodal imaging magnetic resonance imaging (MRI), computed tomography (CT), bone scintigraphy, positron emission tomography (PET)/CT demonstrated a heterogeneous hepatic mass with extensive calcifications, rim enhancement, restricted diffusion, and elevated fluorine-18-fluorodeoxyglucose (18F-FDG) uptake. Histopathological analysis confirmed the diagnosis, showing atypical mesenchymal cells producing osteoid matrix with strong special AT-rich sequence-binding protein 2 (SATB2) positivity and negative epithelial markers.
DISCUSSION: Imaging characteristics and immunohistochemical profiling were crucial in differentiating PHOS from hepatocellular carcinoma and metastatic osteosarcoma. The case supports the metaplasia theory of PHOS pathogenesis and highlights its radiologic-pathologic correlation, especially the "cloud-like" enhancement on imaging corresponding to unmineralized osteoid and vascular proliferation.
CONCLUSION: This case highlights the diagnostic challenge and clinical significance of PHOS. Comprehensive imaging and pathological evaluation are essential for accurate diagnosis. Due to its rarity and aggressiveness, PHOS requires individualized management strategies, typically involving surgery and adjuvant therapies despite limited evidence-based guidelines.